Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Genomic Vision launches HexaCard, a new service to characterize cell lines for biomanufacturing and gene therapy
, /in Product News /by panglobalGenomic Vision, a biotechnology company that develops products and services for the characterization of DNA sequences, has launched a new service, HexaCard.
Sartorius and Repligen Corporation introduce integrated system with Biostat STR and XCell ATF for upstream process intensification
, /in Product News /by panglobalThe life science group Sartorius and Repligen Corporation have launched of an integrated bioreactor system that incorporates Repligen XCell ATF upstream intensification technology into Sartorius’ Biostat STR bioreactor, simplifying intensified seed train and N perfusion implementation for biopharmaceutical manufacturers. The Biostat STR now contains a fully compatible embedded XCell ATF hardware and software module offering […]
Waters launches XBridge Premier GTx BEH SEC Columns for gene therapy applications
, /in Product News /by panglobalWaters Corporation has introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors. The new Waters XBridge Premier GTx BEH SEC columns doubles the speed of measuring the potency and safety of AAVs. Combining the […]
Siemens Healthineers Atellica CI Analyzer for smaller labs receives FDA approval
, /in Product News /by panglobalSiemens Healthineers’ Atellica CI Analyzer for immunoassay and clinical chemistry testing, has received FDA clearance and is now available in many of the world’s major markets. It is the latest addition to the Siemens Healthineers Atellica in vitro diagnostics portfolio.
Tillotts Pharma and TVM Capital Life Science form Mage Biologics to develop oral antibody therapy for ulcerative colitis
, /in E-News /by panglobalTVM Capital Life Science, a leading international venture capital firm focused on investments in life sciences innovation, together with specialty pharma company, Tillotts Pharma, will jointly invest up to US$28 million in the newly formed U.S.-based biotechnology company, Mage Biologics. TVM will invest with its fund TVM Life Science Innovation II SCSp (TVM LSI II) […]
Exothera to manufacture Meissa Vaccines’ paediatric RSV vaccine candidate for Phase 2 trials
, /in E-News /by panglobalMeissa Vaccines, a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, has entered into a manufacturing agreement with Exothera, a Univercells company and full-service Contract Research Development and Manufacturing Organization (CRDMO). Exothera delivers customized process development and GMP manufacturing services for vaccines, viral vectors and nucleic acids. Under the agreement, Exothera will manufacture […]
DLOC partners with 42 Technology to develop ‘human-on-chip’ system
, /in E-News /by panglobalDLOC Biosystems (DLOC), a spin-out from the American University of Beirut, has appointed UK-based 42 Technology (42T) as a strategic product development partner to help bring its advanced 3D human-on-chip technology and fully-automated operating system to market.
NK:IO raises more funding to advance pioneering NK cell therapy
, /in E-News /by panglobalNK:IO, a leader in natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has raised £1.2 million (about US$1.5 million). This brings total equity financing to £3.2 million and will enable the company to reach key milestones in progressing its differentiated NK cell therapy candidates into […]
Celonic Group appoints new CEO
, /in E-News /by panglobalCelonic Group, a Swiss-based Biologics Contract Development and Manufacturing Organization (CDMO), has appointed Dr Samanta Cimitan as the Chief Executive Officer (CEO) of the Celonic Group, a subsidiary of the independent and privately owned J. Rettenmaier & Söhne Company (JRS Group).
Evotec signs 3-year agreement for unlimited use of Titian Software’s Mosaic Sample Management Platform
, /in E-News /by panglobalTitian Software, a global leader in life sciences sample management software, and the life science company Evotec have signed a three-year agreement to expand their collaboration around Titian Software’s Mosaic Sample Management Platform. Mosaic forms part of Evotec’s plans to expand and harmonise sample management throughout the organisation, underpinning its expanding services. The new agreement […]